Arca
Skip to content
Tools
Tools

Nio 5MP-M-21 (Nio 5MP Mammo) and 1 more

System, Image Processing, Radiological. 510(k) K062131, from Barcoview (Kortrijk, BE). Product code LLZ, class 2.

As of Nov 18, 2026, K062131 is an FDA 510(k) held by Barcoview, substantially equivalent on Nov 17, 2006 after 114 days, with no recalls tied to it in FDA's recall database.

  • Review time: 114 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

"The MDNG-5121 BB is intended to be used in displaying and viewing digital images, including digital mammography, for review and analasys by trained medical practitioners.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Other LLZ clearances

The newest 510(k)s for the same product code; their median review was 145 days; see every LLZ device

Record

Type
Traditional
Received
Jul 26, 2006
Review panel
Radiology
Regulation
21 CFR 892.2050

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.